These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35917806)

  • 1. The Effects of Oxytocin on Craving, Mental Health Parameters, and Stress Hormones in Methamphetamine-Dependent Patients Undergoing Matrix Treatment Model: A Randomized, Double-Blind Clinical Trial.
    Azadbakht A; Salehi M; Maracy MR; Banafshe HR
    Eur Addict Res; 2022; 28(5):340-349. PubMed ID: 35917806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients: A Randomized, Double-Blind Clinical Trial.
    Moeini M; Omidi A; Sehat M; Banafshe HR
    Eur Addict Res; 2019; 25(1):41-47. PubMed ID: 30630161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomoxetine Efficacy in Methamphetamine Dependence during Methadone Maintenance Therapy.
    Rabiey A; Hassani-Abharian P; Farhad M; Moravveji AR; Akasheh G; Banafshe HR
    Arch Iran Med; 2019 Dec; 22(12):692-698. PubMed ID: 31823620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chronic oxytocin treatment during abstinence from methamphetamine self-administration on incubation of craving, reinstatement, and anxiety.
    Everett NA; Baracz SJ; Cornish JL
    Neuropsychopharmacology; 2020 Mar; 45(4):597-605. PubMed ID: 31715618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
    Stauffer CS; Moschetto JM; McKernan SM; Hsiang E; Borsari B; Woolley JD
    Trials; 2019 Feb; 20(1):145. PubMed ID: 30791944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
    Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
    Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.
    Rezaei F; Emami M; Zahed S; Morabbi MJ; Farahzadi M; Akhondzadeh S
    Daru; 2015 Jan; 23(1):2. PubMed ID: 25588930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder.
    Aryan N; Banafshe HR; Farnia V; Shakeri J; Alikhani M; Rahimi H; Sehat M; Mamsharifi P; Ghaderi A; Omidi A
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):72. PubMed ID: 32977820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled Trial.
    Kheirabadi GR; Bahrami M; Shariat A; Tarrahi M
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):45-48. PubMed ID: 33347022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal oxytocin treatment does not attenuate the hypothalamo-pituitary-adrenal axis in beef heifers subjected to isolation stress or restraint and isolation stress.
    Wagner BK; Relling AE; Kieffer JD; Parker AJ
    Domest Anim Endocrinol; 2020 Jan; 70():106379. PubMed ID: 31479924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial.
    Farahzadi MH; Moazen-Zadeh E; Razaghi E; Zarrindast MR; Bidaki R; Akhondzadeh S
    J Psychopharmacol; 2019 Mar; 33(3):305-315. PubMed ID: 30526230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin enhances cognitive control of food craving in women.
    Striepens N; Schröter F; Stoffel-Wagner B; Maier W; Hurlemann R; Scheele D
    Hum Brain Mapp; 2016 Dec; 37(12):4276-4285. PubMed ID: 27381253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated oxytocin treatment during abstinence inhibited context- or restraint stress-induced reinstatement of methamphetamine-conditioned place preference and promoted adult hippocampal neurogenesis in mice.
    Cai J; Che X; Xu T; Luo Y; Yin M; Lu X; Wu C; Yang J
    Exp Neurol; 2022 Jan; 347():113907. PubMed ID: 34715133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin-enhanced group therapy for methamphetamine use disorder: Randomized controlled trial.
    Stauffer CS; Moschetto JM; McKernan S; Meinzer N; Chiang C; Rapier R; Hsiang E; Norona J; Borsari B; Woolley JD
    J Subst Abuse Treat; 2020 Sep; 116():108059. PubMed ID: 32741502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
    Rezaei F; Ghaderi E; Mardani R; Hamidi S; Hassanzadeh K
    Fundam Clin Pharmacol; 2016 Jun; 30(3):282-9. PubMed ID: 26751259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J; Razeghian Jahromi L
    Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.
    De La Garza R; Newton TF; Haile CN; Yoon JH; Nerumalla CS; Mahoney JJ; Aziziyeh A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):141-6. PubMed ID: 22230648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.